Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government funding notice about potential delays and current operating status, plus a link to cc.nih.gov and opm.gov for updates. - Bumped version from v3.1.0 to v3.2.0.SummaryDifference4%
- Check22 days agoChange DetectedVersion bump to v3.1.0 and capitalization normalization from 'Beta thalassemia' to 'Beta Thalassemia'.SummaryDifference0.2%
- Check36 days agoChange DetectedUpdated to Revision v3.0.2; removed the v3.0.1 reference and the 'Back to Top' element. No other substantive changes detected.SummaryDifference0.3%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical topics related to beta thalassemia and various diseases. However, several previous location details and related topics have been removed.SummaryDifference2%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.